Close



Jun 17, 2022 07:02AM
Jun 17, 2022 07:00AM
May 26, 2022 05:00PM
Apr 13, 2022 09:15AM
Apr 13, 2022 05:32AM
Apr 13, 2022 02:05AM
Jan 31, 2022 06:08AM Sierra Oncology Inc (SRRA) PT Raised to $51 at H.C. Wainwright
Jan 25, 2022 07:19AM
Jan 25, 2022 07:01AM
Jan 25, 2022 07:00AM
Jan 25, 2022 07:00AM
Jan 19, 2022 12:00PM
Jan 18, 2022 07:02AM
Jan 18, 2022 07:00AM Sierra Oncology Updates Topline Data Timing for Pivotal Phase 3 Trial of Momelotinib in Myelofibrosis
Dec 14, 2021 05:53AM
Dec 13, 2021 06:34PM
Dec 6, 2021 07:00AM
Nov 4, 2021 09:00AM
Aug 5, 2021 04:10PM
Jun 21, 2021 07:00AM
May 7, 2021 07:00AM Sierra Oncology Reports First Quarter 2021 Results
Nov 25, 2020 07:00AM
Nov 12, 2020 07:00AM
Nov 5, 2020 08:00AM
Nov 5, 2020 07:00AM
Oct 2, 2020 07:00AM
Sep 14, 2020 07:00AM
Aug 6, 2020 07:05AM Sierra Oncology Strengthens Management Team to Implement North American Pre-Commercialization Strategy for Momelotinib
Aug 6, 2020 07:00AM
Jul 28, 2020 07:00AM
Jun 12, 2020 06:22AM
Jun 12, 2020 02:30AM
May 27, 2020 07:00AM
May 26, 2020 07:02AM
May 26, 2020 07:00AM Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
May 14, 2020 09:00AM
May 7, 2020 08:00AM
May 7, 2020 07:00AM
Mar 3, 2020 07:00AM
Feb 26, 2020 07:00AM
Feb 25, 2020 07:00AM
Feb 6, 2020 07:00AM Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead
Jan 22, 2020 07:03AM
Jan 22, 2020 07:00AM
Dec 7, 2019 09:00AM
Dec 2, 2019 07:00AM
Nov 26, 2019 07:00AM
Nov 20, 2019 07:09AM
Nov 20, 2019 07:00AM Sierra Oncology Launches the MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis
Nov 14, 2019 04:05PM

251,410 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All